Position in AZN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$29,830,259
+$2,785,088 QoQ
Shares Held
157,316
+14.7% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#194
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Epoch Investment Partners, Inc. holds $994,368,960 across 9 Drug Manufacturers - General names. AZN ranks #8 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
1,376,588 | $346,404,603 | |
| 2 | LLY |
ELI LILLY & Co
|
119,698 | $143,569,383 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,050,056 | $134,932,195 | |
| 4 | JNJ |
Johnson & Johnson
|
524,387 | $133,178,566 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
1,141,710 | $65,785,328 | |
| 6 | PFE |
Pfizer Inc
|
2,723,573 | $65,583,636 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
485,736 | $61,367,885 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
157,316 | $29,830,259 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,830,259 | 157,316 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $27,045,171 | 137,132 | Shares | Defined | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||